Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19 is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0.406. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.406
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5U19AI100627-09
Systems Approach to Immunity and Inflammation
National Institutes of Health
Grant: 3U54CA260517-02S2
Mechanisms and Duration of Immunity to SARS-CoV-2
National Institutes of Health
Grant: 5R35GM137936-05
Harnessing the human monocyte system to improve surgical recovery
National Institutes of Health
Grant: 5R35GM138353-03
Machine Learning for Integrative Modeling of the Immune System in Clinical Settings
National Institutes of Health
Grant: 2T32GM089626-11
Research in Anesthesia Training Program (ReAP)
National Institutes of Health
Grant: 3U19AI057229-18S1
Influenza responses and repertoire in vaccination, infection and tonsil organoids.
NIAID NIH HHS
Grant: U19 AI057229
NCI NIH HHS
Grant: HHSN261201500003C
NIGMS NIH HHS
Grant: R35 GM138353
NCI NIH HHS
Grant: HHSN261201500003I
NIGMS NIH HHS
Grant: T32 GM089626
NIGMS NIH HHS
Grant: R35 GM137936
Doris Duke Charitable Foundation
Grant: 2018100
NIGMS NIH HHS
Grant: R01 GM130900
NCI NIH HHS
Grant: U54 CA260517
NIAID NIH HHS
Grant: K23 AI146268
NIAID NIH HHS
Grant: U19 AI100627
Fields of Study
Keywords
Sustainable Development Goals
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19